Our AMR collection is live

Read our dedicated collection that showcases companies developing new therapies designed to tackle the serious global threat of antimicrobial resistance.

Advertisement

  • CalciMedica, a clinical-stage biopharma company, is developing potentially first-in-class small molecules to combat excessive intracellular calcium levels that drive pathological processes in inflammatory diseases and acute injury, including COVID-19.

    • CalciMedica Inc.
    Advertisement Feature
  • Reacta Healthcare produces pharmaceutical grade oral food challenges (OFCs) for diagnosing and establishing the severity of food allergies. The company’s standardized OFC for peanut is currently used in clinical trials of food allergy therapies in the UK, EU, and North America.

    • Reacta Healthcare
    Advertisement Feature
  • Targeting allergies and beyond, biotechnology company Angany is combining immunotherapy and anti-viral approaches for the development of innovative eBioparticles designed to increase immunogenicity and decrease allergenicity.

    • Angany
    Advertisement Feature
  • Switzerland-based Rejuveron is building a portfolio of innovative subsidiary companies that are all dedicated to discovering therapies to promote healthy aging.

    • Rejuveron Life Sciences AG
    Advertisement Feature
  • Chameleon Biosciences is developing next-generation adeno-associated virus vectors that elicit minimal immune responses, allowing repeat dosing and resulting in superior efficacies. These EVADER vectors have universal application for existing adeno-associated virus vectors, and Chameleon is seeking partners to advance its lead program in severe hemophilia B and to programs that target retinal cells.

    • Chameleon Biosciences
    Advertisement Feature
  • With its lead phase 3 candidate Nefecon in development for the treatment of primary immunoglobulin A nephropathy and a late-stage orphan focused NOX program, Calliditas Therapeutics is pioneering new rare-disease therapies.

    • Calliditas Therapeutics
    Advertisement Feature
The search for rare disease therapies

The search for rare disease therapies

Complex, genetic and rare diseases continue to pose challenges globally, but new targeted approaches and personalized therapies are accelerating progress in the field. Here we present rare diseases therapies in development.
Collection